These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10681409)

  • 1. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
    Tsukamoto K; Maugeais C; Glick JM; Rader DJ
    J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
    Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
    J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M; Iso-O N; Satoh H; Noto H; Togo M; Ishibashi S; Kimura S; Kadowaki T; Hashimoto Y; Tsukamoto K
    Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
    Tsukamoto K; Smith P; Glick JM; Rader DJ
    J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion.
    Mensenkamp AR; Teusink B; Baller JF; Wolters H; Havinga R; van Dijk KW; Havekes LM; Kuipers F
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1366-72. PubMed ID: 11498467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW
    J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression.
    Gerritsen G; Rensen PC; Kypreos KE; Zannis VI; Havekes LM; Willems van Dijk K
    J Lipid Res; 2005 Jul; 46(7):1466-73. PubMed ID: 15863838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice.
    Maugeais C; Tietge UJ; Tsukamoto K; Glick JM; Rader DJ
    J Lipid Res; 2000 Oct; 41(10):1673-9. PubMed ID: 11013310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR; van Luyn MJ; van Goor H; Bloks V; Apostel F; Greeve J; Hofker MH; Jong MC; van Vlijmen BJ; Havekes LM; Kuipers F
    J Hepatol; 2000 Aug; 33(2):189-98. PubMed ID: 10952236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
    J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.